Aerodigestive tract papillomatosis: Bacille calmette-guérin (BCG) immunotherapy

Melvin Strauss, George H. Conner, Harold A. Harvey, Deborah S. White

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aerodigestive tract papillomatosis (ADTP) remains a distinct challenge for the otolaryngologist. None of the myriads of therapies utilized to date offers a distinctly improved prognosis with less frequent clinical recurrences or absolute cure rates. Significant complications are avoided by withholding tracheotomy whenever possible and avoiding overly aggressive papilloma removal. Laser technology seems to offer a distinct benefit as regards the latter. Despite much activity in this area, little new knowledge has actually influenced the outcome of patients afflicted with papillomatosis. The disorder remains one of long-term morbidity in those acquiring it early in life and one with a significant rate of mortality for those with involvement of the lower airway. A review and selected discussion of our experience at The Milton S. Hershey Medical Center of The Pennsylvania State University with ADTP from 1974 to 1981 is presented. Nineteen patients ranging in age at the time of presentation from 1.5 to 68 years old have been diagnosed and treated. For the most part, therapy consisted of repeated microendoscopies with forceps removal of papillomas until recurrences ceased. However, in four adult patients with either rapidly recurring laryngeal and/or tracheobronchial papillomas, bacille Calmette-Guerin (BCG) immunotherapy has been administered. Two of these patients are evaluable for greater than 12 months. The rationale and efficacy of the treatment of a high risk group in this fashion are discussed.

Original languageEnglish (US)
Pages (from-to)971-975
Number of pages5
JournalLaryngoscope
Volume92
Issue number9
StatePublished - Sep 1982

Fingerprint

Papilloma
Immunotherapy
Recurrence
Tracheotomy
Surgical Instruments
Lasers
Technology
Morbidity
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Strauss, Melvin ; Conner, George H. ; Harvey, Harold A. ; White, Deborah S. / Aerodigestive tract papillomatosis : Bacille calmette-guérin (BCG) immunotherapy. In: Laryngoscope. 1982 ; Vol. 92, No. 9. pp. 971-975.
@article{ef8a27b43fdc4b3487dee36c4d107b02,
title = "Aerodigestive tract papillomatosis: Bacille calmette-gu{\'e}rin (BCG) immunotherapy",
abstract = "Aerodigestive tract papillomatosis (ADTP) remains a distinct challenge for the otolaryngologist. None of the myriads of therapies utilized to date offers a distinctly improved prognosis with less frequent clinical recurrences or absolute cure rates. Significant complications are avoided by withholding tracheotomy whenever possible and avoiding overly aggressive papilloma removal. Laser technology seems to offer a distinct benefit as regards the latter. Despite much activity in this area, little new knowledge has actually influenced the outcome of patients afflicted with papillomatosis. The disorder remains one of long-term morbidity in those acquiring it early in life and one with a significant rate of mortality for those with involvement of the lower airway. A review and selected discussion of our experience at The Milton S. Hershey Medical Center of The Pennsylvania State University with ADTP from 1974 to 1981 is presented. Nineteen patients ranging in age at the time of presentation from 1.5 to 68 years old have been diagnosed and treated. For the most part, therapy consisted of repeated microendoscopies with forceps removal of papillomas until recurrences ceased. However, in four adult patients with either rapidly recurring laryngeal and/or tracheobronchial papillomas, bacille Calmette-Guerin (BCG) immunotherapy has been administered. Two of these patients are evaluable for greater than 12 months. The rationale and efficacy of the treatment of a high risk group in this fashion are discussed.",
author = "Melvin Strauss and Conner, {George H.} and Harvey, {Harold A.} and White, {Deborah S.}",
year = "1982",
month = "9",
language = "English (US)",
volume = "92",
pages = "971--975",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

Strauss, M, Conner, GH, Harvey, HA & White, DS 1982, 'Aerodigestive tract papillomatosis: Bacille calmette-guérin (BCG) immunotherapy', Laryngoscope, vol. 92, no. 9, pp. 971-975.

Aerodigestive tract papillomatosis : Bacille calmette-guérin (BCG) immunotherapy. / Strauss, Melvin; Conner, George H.; Harvey, Harold A.; White, Deborah S.

In: Laryngoscope, Vol. 92, No. 9, 09.1982, p. 971-975.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aerodigestive tract papillomatosis

T2 - Bacille calmette-guérin (BCG) immunotherapy

AU - Strauss, Melvin

AU - Conner, George H.

AU - Harvey, Harold A.

AU - White, Deborah S.

PY - 1982/9

Y1 - 1982/9

N2 - Aerodigestive tract papillomatosis (ADTP) remains a distinct challenge for the otolaryngologist. None of the myriads of therapies utilized to date offers a distinctly improved prognosis with less frequent clinical recurrences or absolute cure rates. Significant complications are avoided by withholding tracheotomy whenever possible and avoiding overly aggressive papilloma removal. Laser technology seems to offer a distinct benefit as regards the latter. Despite much activity in this area, little new knowledge has actually influenced the outcome of patients afflicted with papillomatosis. The disorder remains one of long-term morbidity in those acquiring it early in life and one with a significant rate of mortality for those with involvement of the lower airway. A review and selected discussion of our experience at The Milton S. Hershey Medical Center of The Pennsylvania State University with ADTP from 1974 to 1981 is presented. Nineteen patients ranging in age at the time of presentation from 1.5 to 68 years old have been diagnosed and treated. For the most part, therapy consisted of repeated microendoscopies with forceps removal of papillomas until recurrences ceased. However, in four adult patients with either rapidly recurring laryngeal and/or tracheobronchial papillomas, bacille Calmette-Guerin (BCG) immunotherapy has been administered. Two of these patients are evaluable for greater than 12 months. The rationale and efficacy of the treatment of a high risk group in this fashion are discussed.

AB - Aerodigestive tract papillomatosis (ADTP) remains a distinct challenge for the otolaryngologist. None of the myriads of therapies utilized to date offers a distinctly improved prognosis with less frequent clinical recurrences or absolute cure rates. Significant complications are avoided by withholding tracheotomy whenever possible and avoiding overly aggressive papilloma removal. Laser technology seems to offer a distinct benefit as regards the latter. Despite much activity in this area, little new knowledge has actually influenced the outcome of patients afflicted with papillomatosis. The disorder remains one of long-term morbidity in those acquiring it early in life and one with a significant rate of mortality for those with involvement of the lower airway. A review and selected discussion of our experience at The Milton S. Hershey Medical Center of The Pennsylvania State University with ADTP from 1974 to 1981 is presented. Nineteen patients ranging in age at the time of presentation from 1.5 to 68 years old have been diagnosed and treated. For the most part, therapy consisted of repeated microendoscopies with forceps removal of papillomas until recurrences ceased. However, in four adult patients with either rapidly recurring laryngeal and/or tracheobronchial papillomas, bacille Calmette-Guerin (BCG) immunotherapy has been administered. Two of these patients are evaluable for greater than 12 months. The rationale and efficacy of the treatment of a high risk group in this fashion are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0019906276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019906276&partnerID=8YFLogxK

M3 - Article

C2 - 7121166

AN - SCOPUS:0019906276

VL - 92

SP - 971

EP - 975

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 9

ER -